Study guide

10.2 Recordkeeping, Storage & Handling

New York MPJE Pharmacy Jurisprudence Exam

Track your progress as you read

Finished sections get a check mark.

1 Introduction & Exam Overview

1.1 About the NY MPJE Exam 1.2 Study Strategy & Federal vs. New York Law Hierarchy

2 Federal Pharmacy Law: Controlled Substances

2.1 Controlled Substances Act & DEA Scheduling 2.2 DEA Registration, Forms & Security 2.3 Federal Food, Drug, and Cosmetic Act (FDCA)

3 Federal Pharmacy Law: Privacy & Supply Chain

3.1 HIPAA & Patient Privacy 3.2 OBRA '90, Medicare/Medicaid & DUR 3.3 DSCSA & Drug Supply Chain Integrity

4 Area 1a: NYSED, Board & Pharmacist Licensure

4.1 NYSED Office of the Professions, Board of Pharmacy & Education Law Article 137 4.2 Pharmacist Licensure: Education, NAPLEX/MPJE & Internship 4.3 License by Endorsement, Renewal & Continuing Education

5 Area 1b: Interns, Technicians & Discipline

5.1 Pharmacy Interns & Limited Permits 5.2 Registered Pharmacy Technicians (RPhT) & Supervision Ratios 5.3 Professional Misconduct, Discipline & Impaired Practitioner Programs

6 Area 2a: Prescribing, Controlled Substances & Collaborative Practice

6.1 Prescription Requirements & Practitioner Authority 6.2 Controlled Substance Prescribing & the NY EPCS Mandate 6.3 Refills & Authority Limitations 6.4 Collaborative Drug Therapy Management (§6801-a) & Non-Patient-Specific Orders

7 Area 2b: Counseling, Immunization & Public Health

7.1 Patient Counseling & Documentation 7.2 Pharmacist Immunization Authority 7.3 Naloxone Access & Public Health Programs 7.4 Patient Confidentiality & Pharmacy Records

8 Area 3a: Verification, Transfers & DUR/I-STOP

8.1 Legitimate Medical Purpose & Corresponding Responsibility 8.2 Prescription Transfers Between Pharmacies 8.3 Prospective DUR & the I-STOP PMP Registry 8.4 Refill Exceptions & Emergency Dispensing

9 Area 3b: Labeling, Packaging & Substitution

9.1 Labeling of Dispensed Drugs 9.2 Packaging: PPPA & Child-Resistant Containers 9.3 Generic Substitution & Interchangeable Biologics (§6816-a) 9.4 OTC, Behind-the-Counter & Restricted Nonprescription Sales

10 Area 4a: Records, Inventories & Delivery

10.1 Ordering, Acquisition & Distribution Records 10.2 Recordkeeping, Storage & Handling 10.3 Controlled Substance Inventories & BNE Registration 10.4 Delivery & Mail-Order Dispensing

11 Area 4b: Compounding, Central Fill & Facilities

11.1 Compounding: Non-Sterile, Sterile & Hazardous Drugs 11.2 Central Fill, Centralized Processing & Shared Pharmacy Services 11.3 Automated Dispensing & Telepharmacy 11.4 Pharmacy Establishment Registration, Inspections & Discipline

12 Test-Day Strategy & Final Review

12.1 When New York Law Is Stricter Than Federal Law 12.2 Test-Day Strategy & Common Traps

10.2 Recordkeeping, Storage & Handling

Key Takeaways Explain This Topic AI

8 NYCRR §63.6 requires New York pharmacies to retain prescription records (hard copy, electronic, or facsimile) for five years from the date of the most recent filling, not the original date written.

Patient medication profiles must be retained for five years following the date of the most recent entry under §63.6(b)(7), and must include demographics, allergies/adverse reactions, chronic disease states, and medication history.

A pharmacist may access a patient's dispensing history in a shared electronic database only upon the express request of the patient or a person authorized to act on the patient's behalf.

New York sets minimum physical standards for pharmacies: at least 300 square feet overall, at least 100 square feet for compounding/dispensing, and refrigerated storage held between 2°C and 8°C (36°F-46°F).

New York's five-year prescription and patient-profile retention period is substantially longer than the federal two-year minimum for ordinary drug purchase invoices under 21 CFR 1304.04.

Last updated: July 2026

Recordkeeping, Storage & Handling

Beyond controlled substances, every prescription a New York pharmacy fills — legend drugs, prescription-only devices, compounds — creates records governed by 8 NYCRR §63.6 , NYSED's core pharmacy practice regulation. This section covers what must be kept, how long, and how the physical pharmacy must be built and secured to hold it all safely.

Prescription and Patient Record Retention

New York sets a five-year retention floor across the major categories of pharmacy records under §63.6:

Prescription hard copies / electronic prescriptions — retained at the pharmacy for five years from the date of the most recent filling (§63.6(a)(7)(ii)(c)). A prescription refilled several times keeps resetting its own five-year clock from the latest fill, not the original write date.

Facsimile-transmitted prescriptions — the same five-year period applies.

Transferred prescriptions — when a prescription is transferred to or from another pharmacy, the transfer documentation is retained for five years from the date of filling (§63.6(a)(8)(iv)).

Patient medication profiles — maintained in a retrievable form for five years following the date of the most recent entry (§63.6(b)(7)). The profile must capture patient demographics, known allergies and drug reactions, chronic disease states, and medication history — the clinical backbone the pharmacist relies on for drug utilization review (DUR) and counseling.

This is meaningfully longer than the two-year federal minimum for ordinary drug purchase invoices under 21 CFR 1304.04 — a contrast the MPJE likes to test, because candidates who default to "two years, like the DEA rule" for every New York record will get prescription- and profile-retention questions wrong.

Electronic Records and Shared Databases

Electronic prescriptions must be "electronically encrypted" — protected against access, alteration, or use by any unauthorized person (§63.6(a)(7)(ii)(b)). Many New York pharmacies participate in common electronic files or databases shared across multiple pharmacies (chain-wide systems, DUR networks) that hold personally identifiable dispensing information. Under §63.6, a pharmacy accessing such a shared database may pull a patient's information from it only upon the express request of the patient or a person authorized to act on the patient's behalf — a pharmacist cannot browse another pharmacy's fill history on a shared system simply because the system happens to be technically accessible.

Physical Storage, Security & Handling

Section 63.6(b) also sets physical construction and security minimums for the pharmacy premises itself:

Minimum pharmacy size — not less than 300 square feet .

Compounding/dispensing area — not less than 100 square feet within that space.

Refrigeration — temperature-controlled storage maintained between 2°C and 8°C (36°F–46°F) for drugs requiring cold storage.

Radioactive drugs — a separate, secured storage and dispensing area , inaccessible to unauthorized personnel (§63.6(b)(6)(iii)); records of radioactive drug receipt/disposition carry the same five-year retention as other drug records.

General standards — proper sanitary appliances, and the pharmacy kept clean and orderly, with minimum equipment (weighing devices, measuring devices, mortar and pestle) on hand to compound and dispense safely.

Equipment and Compounding Standards

The minimum-equipment list in §63.6(b) is not a suggestion — it is what a BNE or NYSED inspector checks against on a routine or complaint-driven site visit. A pharmacy must have on hand a functioning weighing device accurate enough for the smallest quantities it compounds, a measuring device appropriate to liquid preparations, and a mortar and pestle (or equivalent) for solid and semisolid compounding. Storage areas must be kept in a condition that protects drug integrity: clean, orderly, free of pest activity, and separated so that non-drug stock (cleaning supplies, retail merchandise in a combination store) cannot contaminate or be mistaken for pharmaceutical inventory. Inspectors treat a missing or non-functional required item the same way they treat a missing record — as a recordkeeping/operations deficiency, because the equipment exists specifically to make the compounding and dispensing records that §63.6 requires trustworthy.

These physical and equipment standards work together with the record-retention rules above: a patient medication profile is only as reliable as the counseling and DUR process that feeds it, and that process depends on the pharmacist having accurate weighing and measuring tools, secure refrigerated storage for temperature-sensitive drugs, and a radioactive-drug area that keeps low-frequency but high-risk inventory properly isolated. On the MPJE, a fact pattern that combines a storage deficiency (for example, a broken refrigerator holding insulin at improper temperature) with a documentation question (how long the incident must be documented and retained) is testing whether you can connect the physical-standards rule to the recordkeeping rule rather than treating them as two unrelated topics.

Records & Retention Summary Table

  • Record Citation Retention Starting Point
  • Prescription (hard copy/electronic/fax) §63.6(a)(7)(ii)(c) 5 years Date of most recent filling
  • Transferred prescription documentation §63.6(a)(8)(iv) 5 years Date of filling
  • Patient medication profile §63.6(b)(7) 5 years Date of most recent entry
  • Radioactive drug receipt/disposition §63.6(b)(6) 5 years Date of transaction
  • Federal purchase invoice minimum (contrast) 21 CFR 1304.04 2 years Date of transaction
  • Exam Traps

"How long must a New York pharmacy keep a five-times-refilled prescription on file?" — Five years from the most recent fill, not the original date written.

"Can a pharmacist look up a patient's fill history on a shared chain database without being asked?" — No; access to a shared electronic file is limited to instances where the patient (or an authorized representative) has expressly requested it.

"What is the minimum size of a New York pharmacy?" — 300 square feet overall, with at least 100 square feet set aside for compounding and dispensing.

"Is New York's prescription retention period the same as the DEA's two-year invoice minimum?" — No; New York requires five years for prescriptions and patient profiles under §63.6, well beyond the federal two-year floor for ordinary purchase invoices.